RNA 5' terminus (5' RNA)

The RNA 5' terminus is a pivotal structural region of ribonucleic acid molecules that governs their stability, processing, and translation. In eukaryotic messenger RNA (mRNA), this end is typically modified with a 7-methylguanosine cap (m7G), which is essential for protecting the transcript from degradation by 5'-3' exonucleases and facilitating recruitment of the eIF4F translation initiation complex (Ramanathan et al., 2016, Nature Reviews Molecular Cell Biology). In the context of viral infections, many viruses utilize unique 5' end structures, such as internal ribosome entry sites (IRES) or 5' triphosphates, to bypass host translational control or evade immune detection. The 5' triphosphate group specifically serves as a pathogen-associated molecular pattern (PAMP) that is recognized by the cytosolic receptor RIG-I, triggering a robust type I interferon response (Hornung et al., 2006, Science). Therapeutic strategies targeting the 5' end include small molecule inhibitors of viral capping enzymes, antisense oligonucleotides that bind the 5' untranslated region (UTR) to block translation, and guanosine analogs like Ribavirin that interfere with cap formation (Crotty et al., 2000, Nature Medicine). Additionally, drugs like Baloxavir marboxil target the "cap-snatching" mechanism where viruses steal the 5' end of host mRNAs (Hayden et al., 2018, NEJM). Consequently, the 5' end of RNA represents a versatile target for antiviral, anticancer, and gene-modulatory therapies.

Other names

5' end of RNARNA 5' cap5' untranslated region5' UTR5' triphosphate RNA

Inhibition of viral cap-snatching, competitive inhibition of RNA capping enzymes, steric blockade of translation initiation, or induction of RIG-I-mediated immune signaling.